Published: 2022-09-22 21:41:34.034764Category:ScienceType:IllustrationModel release: No
Share
Interleukin-2 receptor alpha chain (CD25, extracellular domain). CD25 is the target of the monoclonal antibody drug daclizumab, used in the treatment of multiple sclerosis.